troglitazone has been researched along with cromakalim in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altan, VM; Ari, N; Karasu, C; Ozçelikay, AT; Sahilli, M; Yöntem, O | 1 |
1 other study(ies) available for troglitazone and cromakalim
Article | Year |
---|---|
Troglitazone has no effect on K(ATP) channel opener induced-relaxations in rat aorta and in human saphenous veins from patients with type 2 diabetes.
Topics: Animals; Aorta; Chromans; Cromakalim; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; In Vitro Techniques; Isometric Contraction; Male; Middle Aged; Muscle, Smooth, Vascular; Nitroprusside; Potassium Channels; Rats; Rats, Wistar; Reference Values; Saphenous Vein; Thiazoles; Thiazolidinediones; Troglitazone; Vasodilation | 2000 |